Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia
- 25 June 2003
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 54 (1) , 115-119
- https://doi.org/10.1002/ana.10618
Abstract
We recently noted a profound decline in brain sulfatides (ST) in subjects who died with incipient dementia due to Alzheimer's disease. Herein, we measured ST levels in cerebrospinal fluid in cognitively normal elderly and in subjects with mild cognitive impairment due to incipient demenia of the Alzheimer type. There was a significant decrease in cerebrospinal fluid ST and in the ST to phosphatidylinositol ratio in MCI subjects. The ST to phosphatidylinositol ratio accurately differentiated very mildly impaired subjects from controls on an individual basis. The cerebrospinal fluid ST to phosphatidylinositol ratio may be a very useful biomarker for the earliest clinical stage of Alzheimer's disease. Ann Neurol 2003;54:115–119Keywords
This publication has 20 references indexed in Scilit:
- Novel Role for Apolipoprotein E in the Central Nervous SystemJournal of Biological Chemistry, 2003
- Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairmentAnnals of Neurology, 2002
- Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's DiseaseBiochemistry, 2002
- Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's diseaseAnnals of Neurology, 2002
- Increase of Brain Oxidative Stress in Mild Cognitive ImpairmentArchives of Neurology, 2002
- Differences in the A?40/A?42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotypeAnnals of Neurology, 2000
- Biomarkers of Alzheimer DiseaseArchives of Neurology, 1999
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995